NASDAQ:MGCD (MGCD) (MGCD) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free MGCD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$11.03▼$11.0350-Day Range N/A52-Week Range$6.24▼$11.20VolumeN/AAverage Volume15,965 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (MGCD) alerts: Email Address Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. About (MGCD)MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs). Its cardiorespiratory diagnostic products measure flow and respiratory pressures and, in most cases analyze the inhaled and exhaled gases, such as oxygen and carbon dioxide. Its products include pulmonary function (PFT) and gas exchange (GX) testing products. The Company's pulmonary function products are divided into four product categories: Spirometry, Complete Pulmonary Function, Body Plethysmography and Specialty Products.Read More Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. MGCD Stock News HeadlinesJanuary 9, 2024 | msn.comSonu Sood’s ‘Fateh’ is a cinematic tribute to cybercrime victimsDecember 31, 2023 | msn.comLakers' LeBron James irate after foot on line discounts potential tying shot in loss to TimberwolvesApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.November 6, 2023 | msn.com‘Defuse it quickly;’ Police arrest Springfield student who brought gun to football gameApril 5, 2023 | reuters.comSpencer Torkelson knocks in three as Tigers beat AstrosFebruary 11, 2023 | msn.comBusy Wednesday schedule kept Jenna Ortega from returning to You Season 4December 29, 2022 | msn.comWrexham science discovery centre to launch Monday warm hub drop in sessionsDecember 17, 2022 | msn.comF1 News: 2023 Aston Martin AMR23 Reveal Date AnnouncedApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.October 25, 2022 | msn.comThe Northern Belle train returns to Grantham for rare appearance this ChristmasSeptember 28, 2022 | msn.comOpen Thread: Buffalo Sabres vs. Columbus Blue Jackets (Preseason)August 18, 2022 | msn.comL.A. County authorities search for woman, 23, missing since JulySee More Headlines Receive MGCD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (MGCD) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/07/2016Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:MGCD Previous SymbolNASDAQ:ANGN CUSIPN/A CIK815093 Webmgcdiagnostics.com Phone+1-651-4844874FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesGreg GreenbergChairman of the BoardMatthew S. Margolies (Age 50)President Todd M. Austin (Age 54)Chief Executive Officer Larry Robert Degen (Age 62)Interim Chief Financial Officer, Chief Accounting Officer, Secretary Hendrik Struik (Age 49)Independent Director MGCD Stock Analysis - Frequently Asked Questions How were (MGCD)'s earnings last quarter? (MGCD) (NASDAQ:MGCD) issued its quarterly earnings results on Wednesday, September, 7th. The medical equipment provider reported $0.06 EPS for the quarter. The medical equipment provider earned $9.90 million during the quarter, compared to analysts' expectations of $9.20 million. What other stocks do shareholders of (MGCD) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (MGCD) investors own include Allena Pharmaceuticals (ALNA), Akers Biosciences (AKER), Ampliphi Biosciences (APHB), Veru (VERU), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), Achieve Life Sciences (ACHV), AcelRx Pharmaceuticals (ACRX), Acacia Research (ACTG) and Achaogen (AKAO). This page (NASDAQ:MGCD) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (MGCD) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
